Wealthspire Advisors (Maryland)’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,105	Closed	-$4K	–	2603
2018 Q2	$4K	Hold	2,105	–	–	﹤0.01%	1954
2018 Q1	$4K	Hold	2,105	–	–	﹤0.01%	1969
2017 Q4	$5K	Hold	2,105	–	–	﹤0.01%	1868
2017 Q3	$6K	Hold	2,105	–	–	﹤0.01%	1772
2017 Q2	$9K	Hold	2,105	–	–	﹤0.01%	1595
2017 Q1	$10K	Hold	2,105	–	–	﹤0.01%	1356
2016 Q4	$13K	Hold	2,105	–	–	﹤0.01%	1149
2016 Q3	$12K	Hold	2,105	–	–	﹤0.01%	1217
2016 Q2	$8K	Hold	2,105	–	–	﹤0.01%	1249
2016 Q1	$6K	Hold	2,105	–	–	﹤0.01%	1317
2015 Q4	$12K	Buy	+2,105	New	+$12.8K	﹤0.01%	1157

Other funds holding SGYP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s SGYP Position: Q3 2018 in Review

Wealthspire Advisors (Maryland) sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2018, closing a stake of 2,105 shares — an estimated $4K sold.

Wealthspire Advisors (Maryland) first reported a position in SGYP in Q4 2015 and held it in 11 quarters. The position peaked at $13K in Q4 2016. 134 funds tracked by Wall St. Rank hold SGYP as of Q3 2018.

Wealthspire Advisors (Maryland) reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2018 after selling out during the quarter.
Wealthspire Advisors (Maryland) sold 2,105 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2018, an estimated $4K.
Wealthspire Advisors (Maryland) first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2015 and held it in 11 quarters.
Wealthspire Advisors (Maryland)'s Synergy Pharmaceuticals, Inc Common Stock position peaked at $13K in Q4 2016.
134 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2018.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2018, filed 13 Nov 2018.